← Back to Clinical Trials
Recruiting NCT07063056

NCT07063056 Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07063056
Status Recruiting
Phase
Sponsor Medinutra LLC
Condition Triglycerides
Study Type INTERVENTIONAL
Enrollment 64 participants
Start Date 2025-07-18
Primary Completion 2026-09-25

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age 59 Years
Study Type INTERVENTIONAL
Interventions
Curcumin (Longvida™)Half Dose Curcumin (Longvida™)Astaxanthin

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 64 participants in total. It began in 2025-07-18 with a primary completion date of 2026-09-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Two dietary supplements are each being compared to a placebo for the ability to help maintain triglycerides in the normal range. The subjects will be adult men and women with moderately high TG values. Serum triglycerides will be measured before and after 6 weeks of taking 1 capsule per day of either Longvida Curcumin, astaxanthin, or a placebo. A few side blood analysis will also be done. These measures are relevant to low level inflammation.

Eligibility Criteria

Inclusion Criteria: * Triglyceride reading of 140-250 mg/dL * Age 21-59 Exclusion Criteria: * Uncontrolled diabetes * Hypothyroidism or other hormonal problems that have not stabilized * Any liver diseases being actively treated * Cancer * Renal dialysis use * Rheumatoid arthritis and related issues like lupus * Inflammatory bowel disease * Smoking * Low blood pressure * Having more than 5 alcoholic drinks per week * Extreme obesity (BMI over 37) * Pregnancy or lactation

Contact & Investigator

Central Contact

Robert DiSilvestro, Ph.D.

✉ nutritionstudy111@gmail.com

📞 6143489375

Principal Investigator

Robert DiSilvestro, Ph.D.

PRINCIPAL INVESTIGATOR

Medinutra LLC

Frequently Asked Questions

Who can join the NCT07063056 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, up to 59 Years, studying Triglycerides. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07063056 currently recruiting?

Yes, NCT07063056 is actively recruiting participants. Contact the research team at nutritionstudy111@gmail.com for enrollment information.

Where is the NCT07063056 trial being conducted?

This trial is being conducted at Dublin, United States.

Who is sponsoring the NCT07063056 clinical trial?

NCT07063056 is sponsored by Medinutra LLC. The principal investigator is Robert DiSilvestro, Ph.D. at Medinutra LLC. The trial plans to enroll 64 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology